Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

Clin Infect Dis. 2016 Aug 15;63(4):433-42. doi: 10.1093/cid/ciw444.

Abstract

It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.

Keywords: allergic aspergillosis; amphotericin; aspergillosis; azoles; chronic aspergillosis; echniocandins; fungal diagnostics; invasive aspergillosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use*
  • Aspergillosis / diagnosis*
  • Aspergillosis / drug therapy
  • Aspergillosis / epidemiology
  • Azoles / therapeutic use
  • Echinocandins / therapeutic use
  • Humans
  • Infectious Disease Medicine / organization & administration
  • Practice Guidelines as Topic / standards*
  • Societies, Medical
  • United States

Substances

  • Antifungal Agents
  • Azoles
  • Echinocandins
  • Amphotericin B